APS Forum: Toward Precision Cancer Care: Biobehavioral Contributions to the Exposome
October 26, 2012 ˜ Chicago, Illinois


8:30am - 10:15am
I. Models for studying Biobehavioral Contributions to Cancer Risk and Progression

Moderators and Discussants: Paige McDonald, PhD, MPH and Karen Weihs, MD
Stephen Rappaport, PhD
* The Exposome: Using a "top-down" model to study endogenous and exogenous environmental exposures affecting cancer risk and progression across the lifespan
Martha McClintock, PhD
* Ethology: Considering both the environment and the individual's biological responses to study cancer risk and progression across the lifespan
Debate and Discussion
* Focus on Exposure vs. Evolution: What difference does it make for studying biobehavioral contributions to cancer risk and progression?


10:45 am - 12:15 pm
II. STRESS: Embedding individual experience - via biological and molecular pathways

Moderator: Erin Costanzo, PhD
Erica Sloan, PhD

* Stress and beta-adrenergic signaling in Metastatic processes
Michael Antoni, PhD
* Stress management effects on biological and molecular pathways
Steve Cole, PhD
* Linking physiological pathways to translational strategies


1:45 - 2:50 pm
III. ENERGY BALANCE: Embedding individual behavior differences via biological and molecular pathways

Moderator: Janine Giese-Davis, PhD
Christine Friedenreich, PhD
*Physical Activity influences on cancer risk and progression
Jennifer Ligibel, MD
*Diet and Weight influences on cancer risk and progression
Dialogue with audience
*led by Suzanne Conzen, MD: Embedding individual behavior differences via biological and molecular pathways


3:20 - 4:30 pm
IV. CONTEXT: Embedding social processes via biological and molecular pathways
Moderator: Frank J. Penendo, PhD
Susan Lutgendorf, PhD
*Social factors affecting cancer risk and progression
Robert Hiatt, MD, PhD
*Environmental influences on pubertal maturation affecting cancer risk and progression
Dialogue with audience
*led by Martha McClintock, PhD: Translational implications of embedding social processes via biological and molecular pathways


4:30 - 6:00 pm
V. Closing Keynote and Reception Dialogue

Suzanne Conzen, MD
*Toward Precision Cancer Care: Informed by Biobehavioral Contributions to the Exposome
Dialogue with audience *all speakers


Faculty:
Michael Antoni, PhD, Department of Psychology & Biobehavioral Oncology Program, Sylvester Comprehensive Cancer Center, University of Miami, Coral Gables, FL
Steve Cole, PhD, Cousins Center for Psychoneuroimmunology, and Division of Hematology and Oncology, Geffen School of Medicine, UCLA, Los Angeles, CA
Suzanne Conzen, MD, The Ben May Department of Cancer Research, University of Chicago Cancer Center, Chicago, IL
Erin Costanzo, PhD, Department of Psychiatry and Carbone Comprehensive Cancer Center, University of Wisconsin-Madison, Madison, WI
Christine Friedenreich, PhD, Alberta Cancer Board and Community Health Sciences, Calgary, Alberta, Canada
Janine Giese-Davis, PhD, Tom Baker Cancer Centre, Division of Psychosocial Oncology, University of Calgary, Alberta, Canada
Robert Hiatt, MD, PhD, Department of Epidemiology and Biostatistics, UCSF, San Francisco, CA
Michael R. Irwin, MD, Cousins Center for Psychoneuroimmunology, Semel Institute for Neuroscience, UCLA, Los Angeles, CA
Jennifer Ligibel, MD, Dana-Farber Cancer Institute, Boston, MA
Susan Lutgendorf, PhD, Department of Psychology and Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA
Martha McClintock, PhD, University of Chicago, Institute for Mind and Biology, Chicago, IL
Paige McDonald, PhD, MPH, Chief, Basic Biobehavioral and Psychological Sciences Branch and Chair, NCI Network on Biobehavioral Pathways in Cancer, National Cancer Institute, Bethesda, MD
Frank J. Penedo, PhD, Cancer Control and Survivorship Program, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL
Stephen Rappaport, PhD, School of Public Health, University of California-Berkeley, Berkeley, CA
Erica Sloan, PhD, Cousins Center for Psychoneuroimmunology, Semel Institute for Neuroscience, UCLA, Los Angeles, CA
Karen Weihs, MD, Department of Psychiatry and Family Medicine, University of Arizona Cancer Center, Tucson, AZ


Oncology Collage